Is There Need for a New Hepatitis B Vaccine Schedule for Children with Celiac Disease?

Ertekin V. , Tosun M. S. , SELİMOĞLU M. A.

HEPATITIS MONTHLY, cilt.11, sa.8, ss.634-637, 2011 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 11 Konu: 8
  • Basım Tarihi: 2011
  • Doi Numarası: 10.5812/kowsar.1735143x.715
  • Sayfa Sayıları: ss.634-637


Background: Celiac disease (CD) is an autoimmune disease characterized by immune-mediated inflammatory damage of the small intestinal mucosa, precipitated by the ingestion of gluten-containing foods. Since human leucocyte antigen DQ2 (HLA-DQ2) is a marker of nonresponsiveness to hepatits B virus (HBV) vaccine, CD may also be associated with this nonresponsiveness.